A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding.

MLA

Kayser, Veysel, et al. “A Screening Tool for Therapeutic Monoclonal Antibodies: Identifying the Most Stable Protein and Its Best Formulation Based on Thioflavin T Binding.” Biotechnology Journal, vol. 7, no. 1, Jan. 2012, pp. 127–32. EBSCOhost, https://doi.org/10.1002/biot.201100366.

APA

Kayser, V., Chennamsetty, N., Voynov, V., Helk, B., Forrer, K., & Trout, B. L. (2012). A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding. Biotechnology Journal, 7(1), 127–132. https://doi.org/10.1002/biot.201100366

Chicago

Kayser, Veysel, Naresh Chennamsetty, Vladimir Voynov, Bernhard Helk, Kurt Forrer, and Bernhardt L. Trout. 2012. “A Screening Tool for Therapeutic Monoclonal Antibodies: Identifying the Most Stable Protein and Its Best Formulation Based on Thioflavin T Binding.” Biotechnology Journal 7 (1): 127–32. doi:10.1002/biot.201100366.